QuickMIC antibiotic susceptibility tests
Ultra-rapid AST with superior precision
QuickMIC® can speed up blood culture based diagnostics and help improve treatment of sepsis patients. It brings continuous MIC values with superior precision and low variability in 2-4 hours – directly from positive blood cultures.
Gradientech’s technology combines microfluidics with live cell imaging to identify cell responses in a linear concentration gradient.
Clinically actionable AST
QuickMIC is designed to help clinicians make more informed treatment decisions on antibiotic selection and dosage for improved sepsis patient outcomes
Reliable and fast MIC
QuickMIC delivers high accuracy MICs with unprecedented precision. Low variability results in 2-4 hours means ultra-rapid AST you can trust.
Fight antibiotic resistance
Targeted treatment of sepsis patient reduces unnecessary antibiotic use and limit the threat of antibiotic resistance.
Product is available in the following countries:
- Finland
- Estonia
- Latvia
- Lithuania
Links and documents
Manufacturer’s e-book: Next generation antimicrobial susceptibility testing
Contacts
-
Vidas PečiukėnasRegional Sales Representative, Lithuaniavidas.peciukenas@triolab.lt +370 69 880 122